Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Current Opinion in Drug Discovery & Development|December 14, 2002
Synthetic applications of chiral 2,3-dihydro-4-pyridonesSajan Joseph, Daniel L CominsThe Journal of Pharmacology and Experimental Therapeutics|May 12, 2006
Proteomic analysis of rat liver phosphoproteins after treatment with protein kinase inhibitor H89 (N-(2-[p-bromocinnamylamino-]ethyl)-5-isoquinolinesulfonamide)Myrtle A Davis, Douglas Hinerfeld, Sajan Joseph, et al.European Journal of Cancer (Oxford, England : 1990)|January 21, 2014
A phase I trial of LY2584702 tosylate, a p70 S6 kinase inhibitor, in patients with advanced solid tumoursAnthony Tolcher, Jonathan Goldman, Amita Patnaik, et al.Bioorganic & Medicinal Chemistry Letters|July 1, 2004
Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2004
1,7-annulated indolocarbazoles as cyclin-dependent kinase inhibitorsRima S Al-awar, James E Ray, Kyle A Hecker, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2007
Anthranilamide inhibitors of factor XaDavid Mendel, Angela L Marquart, Sajan Joseph, et al.Molecular Cancer Therapeutics|November 21, 2019
ERK Inhibitor LY3214996 Targets ERK Pathway-Driven Cancers: A Therapeutic Approach Toward Precision MedicineShripad V Bhagwat, William T McMillen, Shufen Cai, et al.Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.Pageof 1